Left Atrial Geometry and Phasic Function Determined by Cardiac Magnetic Resonance Are Independent Predictors for

Bianca Olivia Cojan-Minzat1,2, Alexandru Zlibut1, Ioana Danuta Muresan1

  • 1Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Biomedicines
|November 27, 2021
PubMed

Insights

Left atrial (LA) geometry and function, including LA volumes, LA sphericity index (LASI), and LA total strain (LA-εt), are impaired in non-ischaemic dilated cardiomyopathy (NIDCM). These parameters, along with LA late gadolinium enhancement (LA-LGE), predict adverse outcomes in NIDCM patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Cardiovascular Research

Background:

  • Non-ischaemic dilated cardiomyopathy (NIDCM) often involves impaired left atrial (LA) geometry and function.
  • Cardiac magnetic resonance (CMR) is a valuable tool for assessing LA parameters.

Purpose of the Study:

  • To evaluate the prognostic significance of LA geometry and function in NIDCM patients.
  • To determine if LA parameters, including fibrosis, predict adverse cardiovascular events.

Main Methods:

  • Prospective study of 212 NIDCM patients and 106 controls using CMR.
  • Assessment of LA volumes, phasic functions, geometry (LA sphericity index - LASI), and late gadolinium enhancement (LA-LGE).
  • Follow-up for a composite outcome including cardiac death, ventricular arrhythmias, and heart failure hospitalization.

Main Results:

  • NIDCM patients showed significantly impaired LA function, LASI, and increased LA-LGE compared to controls.
  • LA volumes, LASI, LA total strain (LA-εt), and LA-LGE were independently associated with increased risk of the composite outcome.
  • Adding LASI to LA-εt, and subsequently LA-LGE, incrementally improved the predictive value for adverse events.

Conclusions:

  • Impaired LA geometry and function, particularly LASI, LA-εt, and LA-LGE, are significant independent predictors of adverse outcomes in NIDCM.
  • CMR-derived LA parameters offer incremental prognostic information beyond traditional measures in NIDCM.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
44
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
87
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
61
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
75
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
63